Table 1 Laboratory findings of the patient during hospitalization
Day1 (at admission) | Day 3 | Day 7 | Day 12 | Day 25 | Two weeks after discharge | |
|---|---|---|---|---|---|---|
WBC (N: 3.5–9.5*10^9/L) | 12.37 | 6.17 | 15.52 | 9.99 | 5.44 | 6.12 |
RBC (N: 4.3–5.8 *10^9/L) | 3.34 | 2.51 | 2.93 | 2.45 | 2.29 | 2.35 |
PLT (N: 125–350 *10^9/L) | 10 | 23 | 20 | 56 | 254 | 260 |
HGB (N: 130–175 g/L) | 102 | 75 | 89 | 81 | 82 | 113 |
Hypersensitivity C-reactive protein (N: ＜10 mg/L) | 77.4 | 30.2 | 5.1 | 6.9 | ＜10 | / |
Procalcitonin (N＜0.5 ng/ml) | 2.3 | 2.0 | 0.7 | 0.76 | ＜0.5 | / |
TB (N: 3.4–24 umol/L) | 319.6 | 449.2 | 159.6 | 173.1 | 31.7 | 21.7 |
DB (N:≤6.8 umol/L) | 267.5 | 376.3 | 141.4 | 146.0 | 14 | 7.4 |
ALB (N: 40–55 g/L) | 19.4 | 30.2 | 30.8 | 38 | 36.8 | / |
CR (N: 57–97 umol/L) | 139 | 120 | 53.1 | 66.2 | 60.0 | / |
ALT (N: 9–45 U/L) | 484 | 486 | 129 | 57 | 45 | 53 |
AST (N: 15–40 U/L) | 1283 | 956 | 161 | 55 | 47 | 27 |
GGT (N: 10–60 U/L) | 101 | 54 | 35 | 110 | 92 | 92 |
PT (seconds) | 16.1 | 19.4 | 13.3 | 12.4 | 11.2 | 10.1 |
Others | IgG-HEV:5.9 (N＜1.0), IgM-HEV:1.3 (N＜1.0) Negative: IgG-HAV, IGM-HAV, IgG-HDV, IGM-HDV, antibody-HCB, IgM-TORCH, syphilis, ANCA, antinuclear antibodies, ammonia | ADAMTS13 activity (%): 0%, inhibitors of ADAMTS13: positive no abnormal cells with bone marrow puncture |